ArticleCase reports in oncology

Pathological Complete Response to Pembrolizumab plus Axitinib Combination following Serious Immune-Related Adverse Events in an Advanced Renal Cell Carcinoma Patient with a History of Rheumatoid Arthritis.

Marco Bergamini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.